Recurrent pancreatic acinar cell carcinoma following a 7-year disease-free interval: A case report and literature review.
증례보고
2/5 보강
OpenAlex 토픽 ·
Pancreatic and Hepatic Oncology Research
Pancreatitis Pathology and Treatment
Neuroendocrine Tumor Research Advances
[INTRODUCTION AND IMPORTANCE] Pancreatic acinar cell carcinoma (PACC) is a rare malignant pancreatic tumor, accounting for only 1% of all pancreatic neoplasms.
APA
Chorouq Mehdaoui, Abdelkrim Zazour, et al. (2026). Recurrent pancreatic acinar cell carcinoma following a 7-year disease-free interval: A case report and literature review.. International journal of surgery case reports, 138(4), 1152-1161. https://doi.org/10.1097/RC9.0000000000000113
MLA
Chorouq Mehdaoui, et al.. "Recurrent pancreatic acinar cell carcinoma following a 7-year disease-free interval: A case report and literature review.." International journal of surgery case reports, vol. 138, no. 4, 2026, pp. 1152-1161.
PMID
41938435 ↗
Abstract 한글 요약
[INTRODUCTION AND IMPORTANCE] Pancreatic acinar cell carcinoma (PACC) is a rare malignant pancreatic tumor, accounting for only 1% of all pancreatic neoplasms. It has distinctive clinical, radiological, and histological features.
[CASE PRESENTATION] Here, we report a case of PACC diagnosed 7 years after surgical treatment for pancreatic ductal adenocarcinoma (PDAC). The recurrence was suspected during routine follow-up via abdominal computed tomography scan, which showed a local mass without biliary ducts dilation, vascular involvement, or any specific radiological signs. However, clinical examination and laboratory workup, including tumor markers (CA 19-9 and carcinoembryonic antigen), were normal. By comparing samples obtained via endoscopic ultrasound fine-needle aspiration of the pancreatic mass to the histopathological findings of the prior duodenopancreatectomy, a diagnosis of local recurrence of previously misdiagnosed PACC was established.
[CLINICAL DISCUSSION] PACC is a rare pancreatic epithelial malignancy (1%), for which radical surgical resection remains the treatment of choice. However, it is usually diagnosed at an advanced stage (with metastasis). The most common differential diagnoses include pancreatic adenocarcinoma, pancreatic neuroendocrine tumors, solid pseudopapillary neoplasms, and pancreatoblastoma in the pediatric population. Histopathological examination combined with immunohistochemical staining remains the cornerstone for establishing the diagnosis. In our case, ultrasound-guided fine needle aspiration of the pancreatic mass, compared to the previous duodenopancreatectomy, led to the diagnosis of a local recurrence of a previously misdiagnosed initially as PDAC, with the longest survival (84 months) ever described in the literature.
[CONCLUSIONS] Due to its rarity, PACC remains a diagnostic challenge. It has a better prognosis than PDAC; radical resection is recommended.
[CASE PRESENTATION] Here, we report a case of PACC diagnosed 7 years after surgical treatment for pancreatic ductal adenocarcinoma (PDAC). The recurrence was suspected during routine follow-up via abdominal computed tomography scan, which showed a local mass without biliary ducts dilation, vascular involvement, or any specific radiological signs. However, clinical examination and laboratory workup, including tumor markers (CA 19-9 and carcinoembryonic antigen), were normal. By comparing samples obtained via endoscopic ultrasound fine-needle aspiration of the pancreatic mass to the histopathological findings of the prior duodenopancreatectomy, a diagnosis of local recurrence of previously misdiagnosed PACC was established.
[CLINICAL DISCUSSION] PACC is a rare pancreatic epithelial malignancy (1%), for which radical surgical resection remains the treatment of choice. However, it is usually diagnosed at an advanced stage (with metastasis). The most common differential diagnoses include pancreatic adenocarcinoma, pancreatic neuroendocrine tumors, solid pseudopapillary neoplasms, and pancreatoblastoma in the pediatric population. Histopathological examination combined with immunohistochemical staining remains the cornerstone for establishing the diagnosis. In our case, ultrasound-guided fine needle aspiration of the pancreatic mass, compared to the previous duodenopancreatectomy, led to the diagnosis of a local recurrence of a previously misdiagnosed initially as PDAC, with the longest survival (84 months) ever described in the literature.
[CONCLUSIONS] Due to its rarity, PACC remains a diagnostic challenge. It has a better prognosis than PDAC; radical resection is recommended.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Acquired L858R mutation following -TKI resistance in lung adenocarcinoma: a case report.
- Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapy.
- Primary mediastinal mucormycosis presenting with hoarseness: a case report.
- Apocrine Ductal Carcinoma Ex Pleomorphic Adenoma of the Breast: A Rare Case Report.
- Diagnostic Challenge of a Vascular Liver Tumor With Pulmonary Hemorrhagic Metastases: A Case Report.
- Pathological Study of Rare Malignant Cardiac Tumors: A Case Series of Five Patients.